Articles
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective
- Journal/Conference:
- Journal of Medical Economics
- Author(s):
- Kilcoyne, A.; Jordan, E.; Zhou, A.; Thomas, K.; Pepper, A.N.; Chappell, D; Amarapala, M.; Hughes, A.; Thompson, M.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Respiratory
- Condition:
- COVID-19
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
- Journal/Conference:
- Clinicoeconomic Outcomes Research
- Author(s):
- Kilcoyne, A.; Jordan, E.; Thomas, K.; Pepper, A.N.; Zhou, A.; Chappell, D.; Amarapala, M.; Thériault, R.K.; Thompson, M.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Respiratory
- Condition:
- COVID-19
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
- Journal/Conference:
- Multiple Sclerosis and Related Disorders
- Author(s):
- Samjoo IA, Klotz L, Giovannoni G, Drudge C, Haltner A, Worthington E, Zhao M, Brennan R, Häring DA, Cameron C, Adlard N
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Multiple Sclerosis
A systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis
- Journal/Conference:
- Clinical and Experimental Neuroimmunology
- Author(s):
- Drudge C, Zhao M, Tanaka S, Tanaka N, Otaka H, Kawachi I, Häring DA, Brennan R, Adlard N, Samjoo IA
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Nervous System
- Condition:
- Multiple Sclerosis
An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective
- Journal/Conference:
- BMC Health Services Research
- Author(s):
- Morgans AK, Hutson T, Guan AKD, Garcia D, Zhou A, Drea E, Vogelzang NJ
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Prostate Cancer
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Corinne Duperrouzel , Coby Martin, Ari Mendell, Megan Bourque, Adam Carrera, Alicia Mack, Jeffrey Nesheim
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Urology
- Condition:
- Overactive bladder
Comparative assessment of heads-up display and conventional surgical microscope for ergonomic and other benefits in posterior-segment surgeons
- Journal/Conference:
- American Society of Retina Specialists (2022)
- Author(s):
- Downes, R.A.; Ghafouri, R.; Ainslie-Garcia, M.H.; Ferko, N.C.; Cheng, H.; O'Boyle, D.; Ehlers, J.P.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Vision
- Condition:
- Eye
Health Care Resource Utilization With Asciminib And Bosutinib Among Adults With Chronic Myeloid Leukemia In Chronic Phase Previously Treated With ≥2 Tyrosine Kinase Inhibitors: Results From ASCEMBL Trial
- Journal/Conference:
- ISPOR-EU 2022
- Author(s):
- Cortes, J.E.; Sasaki, K.; Réa, D.; Mauro, M.J.; Tran, D.; Wang, P.; Jadhav, K.; Yocolly, A.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Blood, Oncology
Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma
- Journal/Conference:
- Value in Health
- Author(s):
- Martin T, Usmani SZ, Joseph N, Crivera C, Valluri S, Jackson CC, Cohen L, Singh S, Jagannath S.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Blood, Oncology
Comparing the Change from Base Case to Re-Analyzed ICER Values for CADTH Oncology Evaluations
- Journal/Conference:
- Value in Health
- Author(s):
- Stino, M.; Shah, S.; Kipentzoglou, K,; Cameron, C.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Oncology